Physician profile
Ryan K Rush
NPI 1750694907
$2,571.94
in general payments reported to CMS, 2019-2025
9 companies · $466 in 2025
The $466 reported for 2025 was more than what 90% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $537 · 2020: $171 · 2021: $369 · 2023: $1,005 · 2024: $24.06 · 2025: $466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $946 · Travel and Lodging: $308 · Food and Beverage: $241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $945.96 |
| Travel and Lodging | $308.00 |
| Food and Beverage | $241.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $933.93 | 2023-2025 | Opalescence |
| Zimmer Biomet Holdings, INC. | $724.55 | 2019-2021 | |
| Ivoclar Vivadent, INC. | $476.15 | 2023 | |
| Planmeca USA, INC. | $258.45 | 2019 | |
| Nobel Biocare USA | $82.69 | 2019-2021 | |
| Straumann USA LLC | $46.45 | 2023 | |
| Solventum Corporation | $24.06 | 2024 | 3m Filtek |
| 3m Company | $14.48 | 2023 | Scotchbond Universal Plus, 3m Filtek, 3m Espe Filtek Supreme Ultra Universal Restorative |
| Align Technology, INC. | $11.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Rush listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.